Stay Hydrated and Prioritize Protein When digestion is reduced, protein intake can drop, which may slow metabolism
Frias JP, Bastyr EJ 3rd, Vignati L et al (2017) The sustained effects of a dual GIP/GLP-1 receptor agonist, NNC0090-2746, in patients with type 2 diabetes
doi: 10.2337/dc11-1582 21 LordJThomasRFoxBAcharyaUWilkinT
Tirzepatide is a newer GLP-1 drug that targets two hormones instead of just one
Advanced techniques for experienced users Once you have been taking GLP-1 drops for several weeks and have the fundamental technique mastered, these advanced strategies can further optimize absorption and results
Retatrutide is the first of these triple-agonists to reach trials, and early results suggest it could result in up to 30% body weight loss in around 68 weeks